Rezultati pretraživanja
  1. prije 1 sat

    that the majority of patients with PD-L1 negative do not respond to immune checkpoint inhibitor treatments? Learn more about how OncoSec believes can address this unmet need.

  2. Our recent work "Endogenous retroviruses drive KRAB zinc-finger family protein expression for tumor suppression" is out in . drive KZFP gene expression as enhancers in , and suppress

  3. Reminder >> 𝐉𝐄𝐂𝐂𝐑 𝐒𝐩𝐞𝐜𝐢𝐚𝐥 𝐈𝐬𝐬𝐮𝐞 “ and ” is open to submissions.. Submit your article! Click here to view the collection:

  4. prije 15 sati
  5. 4. velj

    A naturally produced in the body has been found to suppress breast metastasis in animal models of human . Natural Body Protein Found to Suppress Breast Cancer Metastasis

  6. 4. velj

    IRP researchers like 's Dr. Xiaoyuan "Shawn" Chen are pioneering cutting-edge techniques to deliver chemotherapy directly to , releasing the toxic compounds only when and where doctors desire.

  7. 4. velj
  8. 4. velj

    A retrospective analysis of stereotactic body radiation therapy for canine : 26 cases.Median overall survival time was 404 d.The majority of dogs experienced a partial response (25%) or stable disease (60%) for a median duration of 333 d

  9. CAR T cell therapies are highly promising to treat , but they can have dangerous side effects. Scientists at EPFL, and have developed a new way to “switch off” the therapy when a cancer patient’s life is in danger.

  10. 3. velj

    As we approach , it is only fitting to discuss cancer. 🧠 When it comes to malignant , prevention and early detection are important. Here are the telltale you should beware of. Read on HERE: 👈

  11. 3. velj

    The company aims to reach phase I for the treatment of a wide range of solid with its lead candidate drug in 2021.

  12. 2. velj
  13. 2. velj

    Through the Fire: from , , & Other Nuisances - miraculous healing journey; remain cancer and tumor-free, through the power and grace of God, prayer, natural remedies, diet, fitness, and perseverance.

  14. 31. sij

    Pacylex has screened PCLX-001 in over 300 different cell lines of both hematological malignancies and solid tumors

  15. 31. sij

    discovery would allow researchers to fine-tune activity of -T cancer-hunting immune cells to heighten their killing power against or to decrease their activity level in the case of severe side effects.

  16. 31. sij

    are better than

  17. 29. sij
  18. 29. sij

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.